Many studies have demonstrated the increased stability of drug encapsulated in nanocarriers for gastrointestinal tract applications,and in some cases,enhanced drug permeability across the epithelial barriers of the gastrointestinal tract was achieved[1].Factors of increasing the extent and rate of particles absorbed in gastrointestinal tract have been extensively described,including size and surface properties of the carrier[2].